Viewing Study NCT04991506

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 1:19 PM
Ignite Modification Date: 2026-04-22 @ 7:30 AM
Study NCT ID: NCT04991506
Status: COMPLETED
Last Update Posted: 2025-06-23
First Post: 2021-07-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors
Sponsor: Elpiscience Biopharma, Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
None Neoplasms View
None Malignant Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ES102 View
None JS001 View
None OX40 View
None PD-1 View
None Solid Tumors View
None Phase 1 View
None INBRX-106 View